Resources

Part of the Technology Updates series, this fact sheet describes PATH's work to develop and evaluate the concept of ready-to-use magnesium sulfate (MgSO4) packs that will eliminate dosing calculation and dilution at the time of use.

Part of the Technology Updates series, this fact sheet describes PATH's work in adapting the concept of a dilution bottle to simplify the process of magnesium sulfate administration for the treatment of preeclampsia and eclampsia. A dilution bottle bottle can facilitate the safe calculation of recommended doses by obviating the need to remember complex equations for dilution.

Part of the Technology Updates series, this fact sheet describes PATH’s work in collaboration with the University of Washington to develop a mobile application for magnesium sulfate administration for the treatment of preeclampsia and eclampsia. The application includes a dosing calculator and a detailed checklist based on World Health Organization protocol and is designed specifically to address the challenges of correctly calculating the dosage.

Part of the Technology Updates series, this fact sheet describes PATH's work to develop, test, and introduce a low-cost balloon tamponade that can be used in low-resource settings to control postpartum hemorrhage.

Cervical Cancer Action is a global partnership chaired by PATH and aimed at reducing cervical cancer in high-burden, low-income countries. Seven years after its founding and eight years after human papillomavirus vaccines first became available, Cervical Cancer Action offers this snapshot of its accomplishments to date and its vision of the work ahead.